Speaker illustration

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital. Dr. Solomon’s research interests have focused on changes in ventricular structure and function following myocardial infarction and in chronic heart failure, and heart failure with preserved ejection fraction, where he has led several phase 2 and phase 3 trials, including the first positive Phase II trial in HFpEF and the PARAGON-HF trial, which led to an expanded FDA indication for sacubitril/valsartan. His lab has pioneered the use of cardiac imaging in clinical trials. He has published over 800 peer reviewed articles, has served as Associate Editor at Circulation, European Heart Journal and European Journal of Heart Failure. He is an editor for the upcoming 12th edition of Braunwald's Heart Disease.

Late-Breaking Trials - Pharmacological treatment II

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

Is HFpEF a disease of women? From biological to epidemiological evidence

Event: Heart Failure 2021 Online Congress

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

Thumbnail

Learning from DAPA-HF one year on

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Industry Q&A session

Thumbnail

Heart failure with preserved ejection fraction

Event: ESC CONGRESS 2019

Topic: Diagnostic Methods

Session type: Advances in Science

Thumbnail

HFpEF - The new HFA consensus

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

Thumbnail

Novel drugs in heart failure

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session type: Symposium

Thumbnail

HFpEF – Still an unsolved enigma?

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiac Biology and Physiology

Session type: Symposium

Thumbnail

Biomarker targeted approach in preventing heart failure among patients with diabetes

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Prevention

Session type: Satellite Symposium

Thumbnail

Meet the Trialists - PRECISION-ABPM

Event: ESC CONGRESS 2017

Topic: Pharmacology

Session type: Meet the Trialists

Thumbnail

Heart failure with preserved ejection fraction

Event: ESC CONGRESS 2016

Topic: Diastolic dysfunction

Session type: Advances in Science

Thumbnail

This platform is supported by

logo Novo Nordisk